Important: Flash Alert

By Paul MampillyPosted December 2, 2014

One of our Ebola companies is now below our 45% stop loss point. All my research and sources tell me that this company’s Ebola medication is likely to be approved and used when Ebola becomes widespread. I still believe that a bigger, wider Ebola outbreak lies ahead. Because of the huge potential gains when that happens, I am going to retain this company in our portfolio…

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Ray Blanco’s FDA Trader

Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.

Paul Mampilly

Back when Paul Mampilly was growing up in India, nobody talked about the stock market. Yet as a kid, Paul read voraciously about the Great Crash of 1929 and found it fascinating.

When he turned 18, he came to the United States by himself. Since then, he’s had close to 25 years of investment...

View More By Paul Mampilly

8,000% on a Stock? For Real? Read On…

By Paul MampillyPosted December 17, 2014

I believe change is coming that could make 2015 the biggest year ever for biotech stocks. We could see returns of 100% for biotechnology indexes and ETFs. And for our FDA Trader, the gains could be far higher… In fact, I believe the coming changes will hand you the chance to make up to 8,000% on one stock in particular…

Flash Sell! Manage Risk and Collect a Triple-Digit Profit

By Ray BlancoPosted July 6, 2016

We are sitting on a gain of over 100%! It’s time to take come money of the table – but we aren’t done with this biotech yet.

Two Picks Set for a Big 2018 as Biotech Breaks Out

By Ray BlancoPosted January 24, 2018

Right now, the Nasdaq Biotechnology Index is already up 8%. It’s turning into another great year for biotech – but it could be even better for the kinds of small cap biotech stocks we deal with. In fact, there are two open positions in our model portfolio that are still under our buy price and have some big catalysts coming up…

Flash Buy! Breakthrough Therapy Equals BIG Profits!

By Ray BlancoPosted June 26, 2019

With a billion-dollar sales estimate and strong Phase 3 results, this biotech’s innovative therapy will deliver gains on a global scale…

FLASH BUY: We’re Raising Our Buy-up-to Price for our Phase 3 Rocket stock

By Josh GrasmickPosted June 3, 2014

Paul called in urgently this morning to let me know that he is increasing your buy-up-to price for our Phase 3 Rocket stock. Our new buy-up-to price is $3.25.

Four Stocks You Can Buy Right Now for “Bazooka” Gains

By Paul MampillyPosted June 25, 2014

Many of you wrote in last week confused about what a trailing stop loss is. And how you should use a trailing stop loss. This week, I want to make it clear what a trailing stop loss is. Why you should use it. And how you should calculate it each day. A trailing stop loss is a way of limiting your losses. A trailing stop loss is a commitment on your part to sell your stock if it goes below a certain price. I'll explain in a bit why you need to keep this commitment to yourself and only give it to your broker when you enter your trade. But before that, let me go over the example I used last week to explain how you should use a trailing stop loss.